Company overview
- Sector
- Education & Research
- Sub-sector
- Research
- Mandate (derived)
- Technology & Engineering
- Parent headquarters
- Waltham, Massachusetts, United States
- Parent revenue (USD)
- $44,600,000,000
- Parent headcount
- 40,675
- India headcount
- Not disclosed
GCC locations
- Bengaluru
- Hyderabad
Department mix
Global department counts, used as a proxy for the India mandate. These are not India team counts.
Technology stack
- .GIS
- .NET
- 24-7 Media
- 3M 360 Encompass - Health Analytics Suite
- ABAP
- ABB Distributed Control Systems (DCS)
- ABB Robotics
- AC500 PLC
- ACL
- ADP
- ADP GlobalView Payroll
- AI
- AMP
- ASP.NET
- AT&T
Public leadership
Vikas Shah
General Manager & Site Head, Clinical Trials Division (CTD) India.
Public leadership listed in the dataset; the role is not necessarily the India GCC head.
Research overview
Thermo Fisher Scientific is a US-based global science and technology company that supplies analytical instruments, laboratory equipment, reagents, consumables, software, and pharma/biotech services (including contract research and clinical trial logistics) to life-sciences researchers, diagnostics providers, pharmaceutical manufacturers, and academic and healthcare customers worldwide.
- India launch
- 2007
- Maturity
- Center of Excellence
Thermo Fisher's own materials label the Bengaluru site an 'R&D Centre of Excellence' combining antibody R&D, software and engineering teams, and the new Hyderabad facility is a specialized bioprocess design center -- both are deep, technically specialized mandates rather than broad shared back-office services, consistent with the stated Technology & Engineering mandate.
Location rationale
The new Hyderabad bioprocess design center was developed in partnership with the Government of Telangana and sited in Genome Valley, the state's established biopharma hub.
Timeline
- 2025
Inaugurated a 37,000 sq. ft. expansion of its R&D Centre of Excellence in Bengaluru (antibody design, development and manufacturing) with an investment of over Rs 160 crore, expected to add 100+ jobs.
- 2025
Opened a new bioprocess design and collaboration center in Genome Valley, Hyderabad, developed in partnership with the Government of Telangana, as part of a wider Asia bioprocessing network expansion.
- 2026
Bengaluru site received the 'Make in India Excellence Award' from the Mumbai Biocluster and Institute of Chemical Technology (ICT) Mumbai.
Leadership context
Vikas Shah has led Thermo Fisher's Clinical Trials Division (CTD) India as General Manager & Site Head since 2024, after roughly 15 years in senior supply-chain leadership roles at Fisher Clinical Services (Director/VP, Supply Chain Management, 2008-2024) and over a decade earlier at Quintiles as Director of Clinical Trial Supplies and Site Management Services.
Real estate
37,000 sq. ft. R&D Centre of Excellence in Bengaluru (2025 expansion), which together with the site's software and scientific product teams employs 1,400+ professionals.
News and developments
Thermo Fisher Expands Bengaluru R&D Centre with Rs 160 Crore Investment
Thermo Fisher inaugurated a 37,000 sq. ft. expansion of its Bengaluru R&D Centre of Excellence focused on antibody design, development and manufacturing, expected to create 100+ jobs; the existing center has produced 2,000+ recombinant antibodies over 18 years.
2025-10-27 BioSpectrum India ↗
Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers
Thermo Fisher announced a new bioprocess design and collaboration center in Genome Valley, Hyderabad -- developed with the Government of Telangana -- alongside expanded centers in Incheon, South Korea and Singapore.
2025-12-02 Business Wire ↗
Thermo Fisher Scientific's Bengaluru Site Honored with Make in India Excellence Award
Thermo Fisher's Bengaluru site received the Make in India Excellence Award from the Mumbai Biocluster and ICT Mumbai, recognizing its contribution to India's life sciences capability building.
2026-03-08 FoodTechBiz ↗
Sources
- Thermo Fisher Corporate Site - Our Company: parentSnapshot ↗
- BioSpectrum India: indiaLaunchYear ↗
- BioSpectrum India: timeline ↗
- Business Wire: timeline ↗
- FoodTechBiz: timeline ↗
- Barchart (Business Wire syndication): locationRationale ↗
- BioSpectrum India: recentNews ↗
- Business Wire: recentNews ↗
- FoodTechBiz: recentNews ↗
- RocketReach (public profile aggregator, sourced from Vikas Shah's public LinkedIn profile): leadershipBio ↗
- BioSpectrum India: realEstate ↗
Sources and research notes
Source: Indian GCC 2026 Master Compendium, Company Master and research records. Sector, mandate and public leadership are derived fields. Missing values are shown as not disclosed. Revenue and global headcount describe the parent company, not the India centre.